Shimura et al. [41] showed that patients with high bone marrow 18F-FDG uptake have increased levels of tumor-derived granulocyte colony-stimulating factor, CD33+ cells, and decreased CD8+ cells. The gene discussed is CD33; the disease is neoplasm.